After the jailbreak tool is downloaded, you can click Start Jailbreak. Jeffrey S.Modular home insurance companies This iPhone iCloud Unlock software offers a free trial version for download along with a paid pro version. Oral anticoagulants may interact adversely with other drugs that bind to plasma proteins or are metabolized by the liver. Plasma that contains normal clotting factors is given to control serious bleeding. Vitamin K, when given intravenously to promote the synthesis of functional clotting factors, stops bleeding after several hours. Hemorrhage is the principal toxic effect during oral anticoagulant therapy. They may cross the placenta to cause fetal abnormalities or hemorrhages in newborns however, their appearance in breast milk apparently has no adverse effect on nursing infants. Oral anticoagulants are metabolized by the liver and excreted in the urine and feces. Oral anticoagulants differ from heparin primarily in their longer duration of action, which is the result of extensive binding to plasma proteins, giving these agents relatively long plasma half-lives. Warfarin, a coumarin derivative and the most commonly used oral anticoagulant, is rapidly and almost completely absorbed. When anticoagulants are taken orally, several hours are required for the onset of the anticoagulant effect because time is required both for their absorption from the gastrointestinal tract and for the clearance of biologically active clotting factors from the blood. Get a Britannica Premium subscription and gain access to exclusive content. The other group of oral anticoagulants, the synthetic indandione derivatives (e.g., anisindione), are thought to work by a similar mechanism of action. Interference in the metabolism of vitamin K in the liver by coumarin derivatives gives rise to clotting factors that are defective and incapable of binding calcium ions (another important element in the activation of coagulation factors at several steps in the coagulation cascade). Structurally, the coumarin derivatives resemble vitamin K, an important element in the synthesis of a number of clotting factors. Heparin-induced hemorrhage may be reversed with the antagonist protamine, a positively charged protein that has a high affinity for heparin’s negatively charged molecules, thus neutralizing the drug’s anticoagulant effect. When oral anticoagulants are given with heparin, additional anticoagulant effects occur. The major side effect associated with heparin is hemorrhage thrombocytopenia (reduced number of circulating platelets) and hypersensitivity reactions also may occur. The drug’s action is terminated by metabolism in the liver and excretion by the kidneys. Heparin is not bound to plasma proteins, it is not secreted into breast milk, and it does not cross the placenta. Because it is not well absorbed from the gastrointestinal tract, heparin is given intravenously to inhibit coagulation immediately, or it is given subcutaneously. Heparin, used primarily in hospitalized patients, is a mixture of mucopolysaccharides that promote the activity of antithrombin III, a blood plasma protein that inactivates thrombin (an enzyme that promotes clotting). Anticoagulants are also used in drawing and storing blood.Īnticoagulants generally are of two types: heparin, which is given by injection, and derivatives of coumarin or indandione, which are administered orally. Conditions commonly treated with anticoagulants include deep-vein thrombosis, in which clots form in so-called deep veins, such as those of the legs pulmonary embolism, in which a clot obstructs the pulmonary artery or one of its branches coronary thrombosis, in which a clot obstructs a coronary artery in the heart and disseminated intravascular coagulation, a systemic activation of the coagulation system that leads to the consumption of coagulation factors and hemorrhage. Such drugs are often used to prevent the formation of blood clots (thrombi) in the veins or arteries or the enlargement of a clot that is circulating in the bloodstream. Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood. Britannica Explains In these videos, Britannica explains a variety of topics and answers frequently asked questions.Īnticoagulant, any drug that, when added to blood, prevents it from clotting.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |